TNF and inflammatory bowel disease: In conclusion, our analysis, conducted in a homogenous and well-matched cohort study, adds to the existing research by confirming the impaired humoral responses to COVID-19 mRNA vaccination in patients with IBD receiving anti-TNF-alpha immunosuppressive therapies.